Thursday, October 10, 2013

Grapefruit, a Big “No” for Statin Users

Medications often interact with other medications, food and beverages, health experts say, and may either decrease or increase the effects of the medication. Fresh grapefruit and its juice are known to interfere with the action of some medications, according to the Food and Drug Administration (FDA). Although there have been some studies that may have point to the ill-effects of grapefruit when taken together with prescription drugs, according to a study published in the British Medical Journal (BMJ), the interaction remains unpredictable. Some patients who have experienced these complications have filed lawsuits but the federal panel denies forming of an MDL to consolidate all the lawsuits.


Grapefruit is indeed beneficial for the health but has become widely known to affect several kinds of medications. Most men and women eat or drink grapefruit because of its vitamins and minerals. Some people believe that it helps in curbing one’s appetite and is quickly becoming a popular fruit for those who want to lose weight. It also good for colds because it has a high percentage of vitamin C. For those who are suffering with high cholesterol, they may also benefit with this fruit because it aids in lowering bad cholesterol while increasing the good cholesterol. All these benefits may make the grapefruit a great partner for those taking statins to lower their cholesterol level but reports say otherwise.  


Bergamottin is a chemical that is present in grapefruit and acts as a potent inhibitor of drugs. When statin and grapefruit is taken together, the bergamottin will deactivate the enzyme that is responsible for breaking down the statins when ingested. If the drug is not metabolized, it will gradually increase in concentration until it reaches toxic levels. As the level of statin rises in the body, it will lead to several side effects. The possible health complications may include muscle, kidney and liver problems. Patients need to ask their health care providers if they may still be able to eat or drink grapefruit. The danger only lies when grapefruit is consumed together with these cholesterol-lowering drugs.


Consuming grapefruit daily is still a great way to stay healthy but patients may need to keep it to a minimum when they are taking medications. There are several ways to decrease the risk for side effects and patients may consult their doctors for possible options. Although there were some people who have experienced severe muscle damage that lead to kidney failure. Hence, some patients decided to file a case against the pharmaceutical company with the help of a Lipitor lawyer.



URL References:
mayoclinic.com/health/statin-side-effects/MY00205/NSECTIONGROUP=2

bmj.com/content/346/bmj.f1/rr/627070

wales.nhs.uk/sitesplus/861/page/53135

fda.gov/forconsumers/consumerupdates/ucm292276.htm

cholesterol.about.com/od/statindrugs/a/grapefruitstat.htm

Friday, June 21, 2013

Lipitor Plaintiffs Petition for Federal Case Consolidation

Five plaintiffs seeking compensatory damages in three different federal lawsuits have filed the motion to consolidate all the federal Lipitor injury lawsuits, online sources say. The motion for a Lipitor multidistrict litigation action was petitioned in the Judicial Panel on Multidistrict Litigation at the United States District Court for the District of South Carolina, according court news reports. Multiple parties with similar claims against Pfizer are able to avoid duplicating information and discoveries making the proceedings to be more efficient.


The pre-trial procedures may allow the both parties to unearth evidences through exchanging of documentations. However, each of the cases will be tried separately for the proper compensation to
lipitor lawyer
be given for each of the plaintiff in the Lipitor MDL against Pfizer. The request for consolidation argued that the plaintiffs have common questions and regarding the awareness of the manufacturer of the increased risk for diabetes among men and women taking Lipitor.

Read More At:
Lipitor Plaintiffs Move to Consolidate Federal Cases

Friday, May 17, 2013

Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP

The firm is currently offering Lipitor lawsuit evaluations to those who have suffered from allegedly serious Lipitor side effects.


(PRWEB) May 09, 2013

For the first time in 55 years, spending on medications in the United States has dropped, in part because of patent expirations for popular drugs such as Lipitor.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on what this means for those who seek to file Lipitor lawsuit because they suffered from Lipitor-induced diabetes.

Pfizer lost patent protection for Lipitor in 2011, which led to other manufacturers’ selling cheaper generic versions of the drug. Given the great number of Lipitor users, that switch to generic plays a large role in reduced spending, according to a May 9 Reuters report.

#Health Blogs - BlogCatalog Blog DirectoryRead more:  Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP